• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Tetratricopeptide repeat protein 37 (TTC37), Truncated

ACP15796

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP15796 Target NameTTC37
Target SynonymsTTC37; KIAA0372; Tetratricopeptide repeat protein 37; TPR repeat protein 37; SKI3 homolog; Ski3; Tricho-hepatic-enteric syndrome protein; ThespinFormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Protein LengthPartial
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ6PGP7
Background Information
  • Uniprot Id

    Q6PGP7

  • Target Species

    Human

  • Target Name

    SKIC3

  • Target Full Name

    Superkiller complex protein 3

  • Target Function

    Component of the SKI complex which is thought to be involved in exosome-mediated RNA decay and associates with transcriptionally active genes in a manner dependent on PAF1 complex (PAF1C).

  • Target Involvement

    Trichohepatoenteric syndrome 1 (THES1)

  • Target Subcellular Location

    Cytoplasm. Nucleus.

  • Target Tissue Specificity

    Widely expressed with the highest levels observed in vascular tissues, lymph node, pituitary, lung and intestine. Not expressed in the liver.

  • Target Synonyms

    TTC37; KIAA0372; Tetratricopeptide repeat protein 37; TPR repeat protein 37; SKI3 homolog; Ski3; Tricho-hepatic-enteric syndrome protein; Thespin

Inquire Recombinant Human Tetratricopeptide repeat protein 37 (TTC37), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification